BR9908825A - Forma cristalina de paroxetina - Google Patents

Forma cristalina de paroxetina

Info

Publication number
BR9908825A
BR9908825A BR9908825-8A BR9908825A BR9908825A BR 9908825 A BR9908825 A BR 9908825A BR 9908825 A BR9908825 A BR 9908825A BR 9908825 A BR9908825 A BR 9908825A
Authority
BR
Brazil
Prior art keywords
paroxetine
crystalline form
free
crystalline
therapy
Prior art date
Application number
BR9908825-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Andrew Simon Craig
Neal Ward
Wilson Mcilwaine
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9805581.7A external-priority patent/GB9805581D0/en
Priority claimed from GBGB9813054.5A external-priority patent/GB9813054D0/en
Priority claimed from GBGB9817115.0A external-priority patent/GB9817115D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9908825A publication Critical patent/BR9908825A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9908825-8A 1998-03-16 1999-03-16 Forma cristalina de paroxetina BR9908825A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9805581.7A GB9805581D0 (en) 1998-03-16 1998-03-16 Novel compounds
GBGB9813054.5A GB9813054D0 (en) 1998-06-17 1998-06-17 Novel compounds
GBGB9817115.0A GB9817115D0 (en) 1998-08-06 1998-08-06 Novel compounds
PCT/GB1999/000793 WO1999047519A1 (en) 1998-03-16 1999-03-16 Crystalline form of paroxetine

Publications (1)

Publication Number Publication Date
BR9908825A true BR9908825A (pt) 2000-11-21

Family

ID=27269245

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908825-8A BR9908825A (pt) 1998-03-16 1999-03-16 Forma cristalina de paroxetina

Country Status (18)

Country Link
EP (1) EP1064282A1 (no)
JP (1) JP2002506865A (no)
KR (1) KR20010041947A (no)
CN (1) CN1300286A (no)
AP (1) AP2000001907A0 (no)
AU (1) AU2847199A (no)
BG (1) BG104839A (no)
BR (1) BR9908825A (no)
CA (1) CA2323896A1 (no)
EA (1) EA200000946A1 (no)
HU (1) HUP0101215A3 (no)
ID (1) ID27596A (no)
IL (1) IL138390A0 (no)
NO (1) NO20004583L (no)
PL (1) PL342931A1 (no)
SK (1) SK13622000A3 (no)
TR (1) TR200002675T2 (no)
WO (1) WO1999047519A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion

Also Published As

Publication number Publication date
EP1064282A1 (en) 2001-01-03
HUP0101215A3 (en) 2002-05-28
SK13622000A3 (sk) 2001-03-12
AP2000001907A0 (en) 2000-09-30
WO1999047519A1 (en) 1999-09-23
BG104839A (en) 2001-09-28
CN1300286A (zh) 2001-06-20
NO20004583L (no) 2000-09-15
JP2002506865A (ja) 2002-03-05
PL342931A1 (en) 2001-07-16
AU2847199A (en) 1999-10-11
IL138390A0 (en) 2001-10-31
NO20004583D0 (no) 2000-09-14
CA2323896A1 (en) 1999-09-23
EA200000946A1 (ru) 2001-02-26
TR200002675T2 (tr) 2000-12-21
HUP0101215A2 (hu) 2002-04-29
ID27596A (id) 2001-04-12
KR20010041947A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
BRPI0014076B8 (pt) benzamidas e inibidores correlatos do fator xa
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
ME00601B (me) Modified factor viii
ATE331534T1 (de) Anwendung von zielgerichtetem radium 223 für palliative und therapeutische behandlung von knochenkrebs
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
BR0114576A (pt) Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto
AR004321A1 (es) Empleo de epinastina para el tratamiento de dolores.
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
AR025964A1 (es) Tratamiento nasal topico
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
BR9912376A (pt) Sais de nitrato, composições farmacêuticas, udo de sais e composições, e, processo para preparação de sais de nitrato.
BR0005824A (pt) Sais de alquilespiroborato para uso em células eletroquìmicas
BR0213072A (pt) Sabonete em barra
BR0208353A (pt) Compostos de diidropirimidina substituìdos com ciano e seu uso para tratar doenças
BR0115036A (pt) Processo para a preparação de um composto
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
PT1030667E (pt) Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono
NO962655D0 (no) Deutrerte virkestoffer i transdermal applikasjon
BR9908825A (pt) Forma cristalina de paroxetina
TR200002203T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
ES2088877T3 (es) Procedimiento de preparacion del 3-pirrolidinol.
PT1294732E (pt) Compostos de rutenio (ii) para utilizacao na terapia do cancro
AP2000001937A0 (en) Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]